The US Food and Drug Administration (FDA) has voluntarily recalled 101 products made by Strauss Israel for potential contamination with Salmonella.
Elite chocolate, cakes, chewing gum, energy chocolate rice cakes, energy grain snacks, and wafers are among the products recalled by Strauss.
The Elite items were distributed to stores in California, Connecticut, Florida, New Jersey, and New York. Amazon, Fresh Direct, Passover.com, and other online stores have also carried kosher chocolates. The FDA's website has a complete list of the products that have been recalled.
The impacted chocolates and candies were created in a facility where Salmonella was discovered in both the liquid chocolate used in the goods and on production line equipment, according to the FDA. Customers who have purchased the products can return them for a full refund, and any merchant who carries them has been requested to remove them from the sale. In addition to the 101 products recalled in the US, the Canadian Food Inspection Agency (CIFA) has discovered 97 potentially contaminated products on the Canadian market.
According to the Strauss Group, they decided to act fully responsibly, not to take any risks, and remove all the factory products from the shelves.
The company also apologized to the Israeli public, customers, and retailers for the difficulty, while thanking them for their patience and vow9ng to get back to all inquiries.
The recall was initially limited to "more than a dozen types of chocolate and chocolate used as raw ingredients," but it was later expanded to include Elite-brand items. Two out of 270 chocolate goods tested positive for salmonella when Strauss tested samples from its plant. Since then, manufacturing at the company's plant has been temporarily halted.
According to the FDA, no illnesses have been linked to the recall in the United States. In Israel, 21 people who consumed the contaminated products developed symptoms that were compatible with salmonella, and the country's Health Ministry took samples from them.


Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Australia’s December Trade Surplus Expands but Falls Short of Expectations
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 



